Adaptive Immunity最新文献

筛选
英文 中文
AI-19 T peripheral helper cells are expanded in the circulation of active SLE patients and correlate with CD21low B cells 活动性SLE患者循环中AI-19 T外周辅助细胞扩增,并与CD21low B细胞相关
Adaptive Immunity Pub Date : 2018-08-01 DOI: 10.1136/LUPUS-2018-LSM.19
Deepak A. Rao, Alexandra V. Bocharnikov, C. Fonseka, J. Keegan, B. Diamond, J. Anolik, P. Nigrovic, S. Raychaudhuri, J. Lederer, M. Brenner
{"title":"AI-19 T peripheral helper cells are expanded in the circulation of active SLE patients and correlate with CD21low B cells","authors":"Deepak A. Rao, Alexandra V. Bocharnikov, C. Fonseka, J. Keegan, B. Diamond, J. Anolik, P. Nigrovic, S. Raychaudhuri, J. Lederer, M. Brenner","doi":"10.1136/LUPUS-2018-LSM.19","DOIUrl":"https://doi.org/10.1136/LUPUS-2018-LSM.19","url":null,"abstract":"Background Pathologic T cell-B cell interactions and production of autoantibodies are hallmark features of SLE. T follicular helper (Tfh) cells are generally considered the principal T cell population capable of helping B cells. However, distinct T cell populations can augment B cell responses in chronically inflamed peripheral tissues. We recently described a dramatically expanded population of T peripheral helper (Tph) cells that promotes B cell responses in synovium of patients with seropositive RA. Here we evaluate the frequency, phenotype, and clinical associations of Tph cells in the circulation of patients with lupus. Methods Mass cytometry data from the Accelerating Medicines Partnership RA/SLE Network were used to quantify cell populations in PBMCs from 27 lupus nephritis patients, 27 RA patients, and 25 non-inflammatory controls. Frequencies of Tph cells (PD-1hi CXCR5- CD4+ T cells), Tfh cells (PD-1hi CXCR5+ CD4+ T cells), and CD21low CD19+ B cells were quantified by standardized gating, and associations with SLEDAI and dsDNA titers were assessed. For in vitro T cell-B cell co-cultures, sorted Tph cells, Tfh cells, or control T cell populations from SLE patients were co-cultured with memory B cells and stimulated with SEB +LPS, and CD38hi CD27+ plasmablasts were quantified at day 5. Results We first confirmed that Tph cells (PD-1hi CXCR5- CD4+ T cells) from SLE patients possess B cell helper function, as we previously observed in RA. Tph cells sorted from blood from 5 different lupus patients strongly induced B cell differentiation into CD38hi CD27+ plasmablasts in vitro (figure 1A, n=5 donors). By mass cytometry, Tph cells are markedly expanded in the circulation of SLE patients compared to non-inflammatory controls (4.3-fold increase, p 50 (p=0.017) and with SELENA-SLEDAI >10 (p=0.046) compared to patients with lower disease activity measures. Similar associations with disease activity were not observed for Tfh cells. Expression of surface receptors on Tph cells from SLE and RA patients was similar. A strong positive correlation emerged between the frequencies of Tph cells and CD21low B cells, an activated B cell population highly expanded in SLE (Spearman r=0.56, p=0.0026, figure 1C, gray=SLE patients, black=all other patients). In contrast, no correlation was seen between Tfh cells and CD21low B cells in SLE patients. Conclusions Tph cells are markedly expanded in the circulation of patients with SLE and demonstrate robust B cell helper function. The strong and specific positive correlation between Tph cell and CD21low B cell frequencies suggests that these cells may act coordinately in the pathologic autoimmune response in SLE. Acknowledgements We acknowledge the Accelerating Medicines Partnership RA/SLE Network and its members.","PeriodicalId":201554,"journal":{"name":"Adaptive Immunity","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116449672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
AI-06 Lupus nephritis is linked to dysbiosis, increased gut leakiness and immunity to an intestinal commensal lachnospiracaea species 狼疮性肾炎与生态失调、肠道渗漏增加和对肠道共生漏螺菌的免疫有关
Adaptive Immunity Pub Date : 2018-08-01 DOI: 10.1136/LUPUS-2018-LSM.6
Gregg J. Silverman, Doua F. Azzouz, Brad H. Rovin, Roberto Caricchio, Jill P. Buyon, Alexander V Alekseyenko
{"title":"AI-06 Lupus nephritis is linked to dysbiosis, increased gut leakiness and immunity to an intestinal commensal lachnospiracaea species","authors":"Gregg J. Silverman, Doua F. Azzouz, Brad H. Rovin, Roberto Caricchio, Jill P. Buyon, Alexander V Alekseyenko","doi":"10.1136/LUPUS-2018-LSM.6","DOIUrl":"https://doi.org/10.1136/LUPUS-2018-LSM.6","url":null,"abstract":"Background A transmissible agent has long been suspected in the pathogenesis of SLE, yet the potential contribution of the human intestinal microbiome has been little examined. We therefore characterized the gut microbiota of patients with SLE, with special interest in those with lupus nephritis (LN). Methods Blood and fecal samples from SLE patients were obtained, with strict inclusion/exclusion of criteria. Fecal 16S rDNA sequencing, as well as cytokine and autoantibody assays were performed. In addition, sera from two independent lupus cohorts were studied for validation. Biomarkers of gut leakiness were assessed. Results Compared to controls, the intestinal microbiome from SLE patients (n=61) showed decreased species richness diversity with reductions in taxonomic complexity most pronounced in those with high disease activity. Notably, SLE patients had an overall 5-fold greater representation of a species in the Lachnospiracaea family of obligate anaerobic Gram-positive cocci, with reciprocal contractions of two other commensal species with putative protective properties. Abundance of the Lachnospiracaea species correlated with serum IgG to a cell wall component, postulated to represent a lipoglycan, from a strain of this same species (p=0.002, n=61, Spearman) but not with 7 other strains. There was also a significant direct correlation between SLEDAI scores and levels of these circulating anti-strain IgG antibodies (p=0.02, n=48). Levels of antibodies to strain-specific bacterial antigen, treated with RNAse/DNAse/proteinase K, were significantly higher in those with active nephritis at time of sampling compared to SLE without renal activity (Cohort 1 p=0.01 n=48; Cohort 2 p=0.006, n=28, Mann-Whitney). Levels of serum IgG anti- strain antibodies also significantly correlated with high-titer serum IgG to native DNA (p Conclusions These findings suggest a novel paradigm for the pathogenesis of LN in which a common intestinal commensal bacteria may contribute to the immune-complex mediated disease process, with features akin to poststreptococcal GN but without outward signs and symptoms of clinical infection. Acknowledgements Judith and Stuart Colton Foundation, NIAMS- P50 AR070591.","PeriodicalId":201554,"journal":{"name":"Adaptive Immunity","volume":"64 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128556237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-13 Therapeutic inhibitors of antigen presentation pathways in SLE AI-13 SLE抗原递呈途径的治疗性抑制剂
Adaptive Immunity Pub Date : 2018-08-01 DOI: 10.1136/LUPUS-2018-LSM.13
Maurice T. Raycroft, R. Gee, J. Merkel, M. Mamula
{"title":"AI-13 Therapeutic inhibitors of antigen presentation pathways in SLE","authors":"Maurice T. Raycroft, R. Gee, J. Merkel, M. Mamula","doi":"10.1136/LUPUS-2018-LSM.13","DOIUrl":"https://doi.org/10.1136/LUPUS-2018-LSM.13","url":null,"abstract":"Background The Mamula laboratory has identified and characterized a novel pathway of antigen presentation in autoimmune disease. In particular, B cells that acquire specific autoantigens can play an important role in triggering autoimmunity in both a direct and indirect manner. First, B cells can directly process autoantigen in triggering T cell autoimmunity. Therapeutics such as Rituxan and Belimumab have been developed to interfere with these direct functions of B cells. In the indirect pathway, autoantigen-bearing B cells form high affinity interactions with scavenger receptor A (SR-A), which is expressed primarily on macrophages (MΦs) and dendritic cells (DCs). After receiving antigen from B cells, MΦs and DCs are then highly competent in activating autoimmune T cells and initiating pathology in models of disease. Our working hypothesis is that identifying small molecules that inhibit the latter pathway will provide leads for developing a new treatment for autoimmunity. Methods and results In brief, we have utilized probes to follow antigen presenting pathways between human B cells and MΦs or DCs. As illustrated in the figure 1, B cells make direct contact with DCs and transfer antigen via a SR-A mediated pathway. We have also identified small molecule inhibitors (SMIs) that interfere with SR-A interactions and interrupt the transfer of autoantigen between B cells and DCs. MRL mice were treated with SMIs of SR-A and the onset and progression of autoimmunity (autoantibodies and autoreactive T cells) were assessed over time. SMI treatment of MRL mice greatly reduced autoAbs and T cell activation as well as tissue pathology. Conclusions This study identifies a novel SR-A dependent pathway of antigen presentation between human B cells and MΦs and DCs. Inhibition of this pathway reduces T cell activation, reduces the production of autoantibodies, and ameliorates kidney and skin pathology of SLE in a murine model.","PeriodicalId":201554,"journal":{"name":"Adaptive Immunity","volume":"115 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132176437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-17 Response gene to complement-32 expression is upregulated in lupus T cells and promotes IL-17A expression AI-17应答基因在狼疮T细胞中表达上调并促进IL-17A表达
Adaptive Immunity Pub Date : 2018-05-01 DOI: 10.1136/LUPUS-2018-LSM.17
Anamaria Talpos-Caia, A. Tatomir, V. Nguyen, C. Cudrici, S. Rednic, H. Rus, V. Rus
{"title":"AI-17 Response gene to complement-32 expression is upregulated in lupus T cells and promotes IL-17A expression","authors":"Anamaria Talpos-Caia, A. Tatomir, V. Nguyen, C. Cudrici, S. Rednic, H. Rus, V. Rus","doi":"10.1136/LUPUS-2018-LSM.17","DOIUrl":"https://doi.org/10.1136/LUPUS-2018-LSM.17","url":null,"abstract":"\u0000 RGC (Response Gene to Complement)-32 is a cell cycle regulator expressed in normal tissues, tumors and a variety of cell lines. RGC-32 is preferentially upregulated in murine Th17 cells and promotes their differentiation. Patients with Systemic Lupus Erythematosus (SLE) display increased serum levels, expanded frequency of IL-17 producing cells. Whether RGC-32 plays a role in human Th17 differentiation pathway and in Th17 abnormalities in lupus patients has not yet been investigated. RGC-32 mRNA expression was determined in CD4+ T cells stimulated under Th0, Th1, Th2, Th17 and Treg conditions and the effect of RGC-32 overexpression and silencing under Th17 conditions was determined by nucleofection. RGC-32 expression was evaluated by RT-PCR, flow cytometry and cDNA Array in PBMC from lupus patients vs controls. RGC-32 mRNA expression was upregulated by TCR stimulation and TGFβ, and was more robust under Th17 (3.2 ± fold) and Treg (2.6 ± 0.8 fold) vs. Th1 (1.3 ± 0.4 fold) and Th2 (1.8 ± 0.1 fold) conditions. Overexpression or silencing of RGC-32 in CD4+ T cells upregulated, respectively downregulated IL-17A transcript levels and protein secretion. RGC-32 mRNA and protein level was significantly increased in CD19+ B cells and CD3+ T from lupus patients compared to controls. These results suggest that RGC-32 promotes the differentiation of human Th17 cells. Furthermore, T cells from patients with SLE exhibit increased expression of RGC-32 compared to controls. These data support the idea that RGC-32 signaling may enhance disease expression in SLE by promoting abnormalities in the Th17 pathway and provide a compelling rationale for further investigating the therapeutic potential of blocking RGC-32 in SLE.","PeriodicalId":201554,"journal":{"name":"Adaptive Immunity","volume":"53 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2018-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126975875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书